Synergy Innovation Co., Ltd. (048870.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩1,375 (+0.59%) as of
Key statistics
- Market cap
- 121.15B
- Dividend yield
- 0.00%
- 52-week range
- 1,329.00 – 2,605.00
- Beta
- 0.08
- Revenue (TTM)
- 116.56B
- Profit margin
- 8.60%
- Volume
- 226.62k
About Synergy Innovation Co., Ltd.
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd. was founded in 1998 and is headquartered in Seongnam-Si, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Seongnam-Si, South Korea
- Employees
- 81
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.